APA (7th ed.) Citation

Reinhard, S., Utikal, J., Zaremba, A., Lodde, G., von Wasielewski, I., Klespe, K. C., . . . Stege, H. (2025). First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG. European journal of cancer, 220, . https://doi.org/10.1016/j.ejca.2025.115356

Chicago Style (17th ed.) Citation

Reinhard, Sören, et al. "First-line Checkpoint Inhibitor Therapy in Metastatic Acral Lentiginous Melanoma Compared to Other Types of Cutaneous Melanoma: A Multicenter Study from the Prospective Skin Cancer Registry ADOREG." European Journal of Cancer 220 (2025). https://doi.org/10.1016/j.ejca.2025.115356.

MLA (9th ed.) Citation

Reinhard, Sören, et al. "First-line Checkpoint Inhibitor Therapy in Metastatic Acral Lentiginous Melanoma Compared to Other Types of Cutaneous Melanoma: A Multicenter Study from the Prospective Skin Cancer Registry ADOREG." European Journal of Cancer, vol. 220, 2025, https://doi.org/10.1016/j.ejca.2025.115356.